← Return to Treatment for chronic Epstein-Barr virus (EBV)

Discussion

Treatment for chronic Epstein-Barr virus (EBV)

Infectious Diseases | Last Active: 4 days ago | Replies (609)
Comment receiving replies
@sharyld

Yes, that's what I have been taking-with only good results. The benefits kicked in after around 10 days and maintained until I ran out the Aatra Isatis for one week while awaiting the next shipment. I will never let that happen again as I had an energy crash and full return of symptoms yesterday! New order has arrived-and it was a definite demonstration of how helpful the supplements have been for me. Currently taking L-Lysine 1000 mg. 3 times daily, 600 mg. Monolaurin twice daily and Astra Isatis, 2 tabs 3 times daily. I take them 8 hour apart. I may increase the Monolaurin to 1800 mg. twice daily based on Dr. Jill Carnahan's recommendations-and may add Olive Leaf, 1000-1500 mg. twice daily and Cat's Claw tincture, 30-60 drops twice daily, also on her advice. I hope you experience improvements soon-this virus is no fun!

Jump to this post

Replies to "Yes, that's what I have been taking-with only good results. The benefits kicked in after around..."
Marianne | @mrmie | Nov 30, 2018

Thanks for the info @sharyld
I've been trying to find Astra Isatis. Are you usung the brand Health Concerns? So glad it is helping you!!!

VIEW AND REPLY
gjul16 | @gjul16 | Dec 8, 2018

I have noticed that a number of group participants use and sometimes advocate for a variety of supplements. I would like to see science-based/evidence-based treatments discussed in this EBV treatment thread. In that vein, here are two articles that might interest readers: 1) "Characterization and Treatment of Chronic Active Epstein-Barr Virus Disease: a 28 Year Experience in the United States" by Jeffrey I. Cohen etal, June 2, 2011. [Dr. Cohen has been mentioned in this thread and is Chief, Medical Virology Section and Chief, Laboratory of Infectious Diseases, National Institutes of Health.] This article paints a stark picture of EBV treatment at the time the article was published.
2) "Chronic Active Epstein-Barr Disease" by Hiroshi Kimura and Jeffrey I. Cohen, Dec 22, 2017.

VIEW AND REPLY